HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Werner Tjarks Selected Research

ErbB Receptors (EGF Receptor)

2/2008Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies.
2/2007Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab.
1/2007Synthesis of cetuximab-immunoliposomes via a cholesterol-based membrane anchor for targeting of EGFR.
11/2004Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.
11/2002Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas.
6/2002Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Werner Tjarks Research Topics

Disease

27Neoplasms (Cancer)
12/2015 - 03/2002
15Glioma (Gliomas)
12/2015 - 06/2002
10Brain Neoplasms (Brain Tumor)
12/2015 - 01/2004
2Anthrax
03/2008 - 12/2006
1Breast Neoplasms (Breast Cancer)
09/2005
1Melanoma (Melanoma, Malignant)
09/2004
1Carcinoma (Carcinomatosis)
07/2003
1Sarcoma (Soft Tissue Sarcoma)
01/2003
1Mouth Neoplasms (Oral Cancer)
08/2002

Drug/Important Bio-Agent (IBA)

17BoronIBA
04/2013 - 03/2002
11ThymidineIBA
12/2015 - 08/2002
7thymidine kinase 1IBA
12/2015 - 09/2004
6Epidermal Growth Factor (EGF)IBA
12/2009 - 06/2002
6ErbB Receptors (EGF Receptor)IBA
02/2008 - 06/2002
6Liposomes (Liposome)IBA
01/2007 - 05/2002
5Dendrimers (Dendrons)IBA
12/2009 - 11/2002
5Cetuximab (Erbitux)FDA Link
02/2008 - 01/2004
5Folic Acid (Vitamin M)FDA LinkGeneric
07/2003 - 05/2002
4Monoclonal AntibodiesIBA
02/2008 - 11/2004
3EnzymesIBA
12/2015 - 09/2004
3NucleosidesIBA
07/2015 - 09/2004
3epidermal growth factor receptor VIIIIBA
02/2008 - 01/2004
2Biological ProductsIBA
09/2006 - 02/2005
1pyrimidineIBA
07/2015
1Thymidine KinaseIBA
07/2015
1EstersIBA
09/2012
1Glycine (Aminoacetic Acid)FDA LinkGeneric
09/2012
1ProdrugsIBA
09/2012
1Amino AcidsFDA Link
09/2012
1Glutamic Acid (Glutamate)FDA Link
09/2012
1Valine (L-Valine)FDA Link
09/2012
1A 7 (A-7)IBA
12/2009
1dTMP kinaseIBA
03/2008
1Anti-Bacterial Agents (Antibiotics)IBA
03/2008
1Phosphates (Orthophosphate)IBA
03/2008
1Thymidine Monophosphate (TMP)IBA
03/2008
1dodecaborateIBA
01/2007
1AnionsIBA
01/2007
1Boron CompoundsIBA
01/2007
1CholesterolIBA
01/2007
1Biological Warfare AgentsIBA
12/2006
1cyanine dye 5IBA
09/2005
1Proteins (Proteins, Gene)FDA Link
09/2005
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2005
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2005
1Nucleic Acid PrecursorsIBA
09/2004
1Boron-10IBA
09/2004
1Ethylene Glycol (Monoethylene Glycol)IBA
01/2003
1Poly(amidoamine)IBA
01/2003
1CytosineIBA
08/2002
1Sulfides (Thioethers)IBA
03/2002

Therapy/Procedure

21Boron Neutron Capture Therapy
07/2015 - 03/2002
12Neutron Capture Therapy
12/2015 - 06/2002
4Therapeutics
04/2013 - 03/2002
1Radiotherapy
01/2012
1Injections
11/2008
1Nuclear Reactors
02/2008